Questcor Pharmaceuticals Inc (NASDAQ:QCOR), saw a high level insider substantially lower his holdings in the company through a series of transactions that began last week on August 6th, continued on the 11th, and were officially filed today, August 13th. Officer Michael H. Mulroy sold a total of 10,000 shares of common stock at prices ranging from $92.07 through $92.77 per share. Following the completion of this transaction, Mulroy now has an overall portfolio containing 65,714 shares directly invested in this corporation.
A $5.6 billion market cap goliath of a company, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) is a biopharmaceutical company that is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the United States food and drug administration (FDA), for the treatment of 19 indications.
Disclosure: The author, Daniel Forstein, holds no positions in any stocks mentioned.